DPP-4 Inhibitors: A New Class of Medications episode artwork

EPISODE · Oct 9, 2009 · 14 MIN

DPP-4 Inhibitors: A New Class of Medications

from Diabetes Discourse

Host: Steven Edelman, MD Guest: Lisa Kroon, PharmD, CD The new class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which stimulate the pancreas to make more insulin after eating a meal, may be changing the way we treat people with type 2 diabetes. Join guest host, Dr. Candis Morello and her guest, professor of clinical pharmacy in the School of Pharmacy at the University of California San Francisco, Dr. Lisa Kroon, as they discuss the use of DPP-4 therapy in the treatment of type 2 diabetes.

Episode metadata supplied by the publisher feed · Published Oct 9, 2009

Embed this episode

NOW PLAYING

DPP-4 Inhibitors: A New Class of Medications

0:00 14:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetes Discourse?

This episode is 14 minutes long.

When was this Diabetes Discourse episode published?

This episode was published on October 9, 2009.

Can I download this Diabetes Discourse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!